Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

By Mariam Sunny and Sneha S K July 1 (Reuters) - Millions of Americans are expected to gain coverage for GLP-1 drugs for ...

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...

The Centers for Medicare and Medicaid Services (CMS) is launching a pilot program on July 1 to subsidize costs of GLP-1s ...

GLP-1 weight loss drugs will be a lot cheaper for many older Americans with the rollout of Medicare’s $50-a-month GLP-1 ...

The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...

Some Medicare beneficiaries could soon pay a flat $50 for GLP-1 drugs. Learn who qualifies, what employers may do, and what ...

Seniors will need to consider whether the Medicare Bridge program is right for them, as it’s set to expire next year — and stopping the drug could have consequences.

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The ...

The proposed changes are relatively modest, yet they represent an important procedural step forward in the implementation of ...

Eli Lilly introduces Medicare GLP-1 bridge program, making weight-loss medications available to 20 million eligible seniors ...

The Centers for Medicare & Medicaid Services July 1 issued its calendar year 2027 proposed rule for the home health prospective payment system. The rule proposes a 2.4% update, which includes a 3.1% ...